Observation and Interactions Between Cardio-respiratory and Motor Transitions at the Limits of Moderate Exercise. (CAREMO)

March 26, 2025 updated by: University Hospital, Grenoble

Observation et Mise en Relation Des Transitions Cardio-respiratoires et Motrices à la frontière de l'Exercice modéré

The goal of this observational study is to learn about physiological transitions around the limit of moderate exercise intensity on cardiac, respiratory and motor modalities, in healthy population.

The main questions it aims to answer is:

  • is it possible to define criteria on cardiac, respiratory and motor modalities to identify transitions?
  • are those transitions visible on embedded and non-intrusive monitoring equipment?
  • are those identified transitions somehow connected to first ventilatory threshold (VT1)?

Participants will do a sub-maximal effort test on cycloergometer calibrated to make them cross their first ventilatory threshold.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Cycling is a commonly prescribed activity when it comes to physical activities for rehabilitation. Because it is soft and progressive effort, cycling suits well for patients with chronic conditions (diabete, cancer, fibromyalgia, ...) For safety and effectiveness of the activity, it is necessary to prescribe activity at a regular and moderate intensity. This can be achieved by personalizing intensities to match specifically the patient health condition in order to build an efficient and progressive rehabilitation program.

Physical activity prescription rely on four pillars: frequency, duration, volume and intensity. While first three pillars are quite easy to regulate,effort intensity is harder to handle on training planning. It is harder to measure, and defining personalized guideline for practice is more complex.

It is known that first ventilatory threshold (VT1) is a individualized marker representing the higher limit of moderate intensity effort zone. It makes it an interesting tool for the prescription of intensity for retraining purposes: it guaranties a safe practice, intense enough to make beneficial physiological adaptations for the patient.

In this retraining context and with this study, we aim to identify markers of this transition on cardiac, respiratory and motor modalities, with embedded and non intrusive equipment, during a sub-maximal effort test in laboratory.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Grenoble, France, 38043
        • Plateforme PRETA P3I

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Heathy volunteers with various physical conditions

Description

Inclusion Criteria:

  • Capability to cycle during 20min
  • No contraindication to cycling at a moderate pace
  • No acute pathology (less than 2 years old)
  • No cardiac or respiratory chronic pathology
  • No locomotive problem on the spine or the lower limbs
  • No recent injuries (less than 2 months)
  • Stature compatible with the use of the plethysmography t-shirt

Exclusion Criteria:

  • Pregnant (urine strip test) or breastfeeding women
  • Persons referred to in articles L1121-5 to L1121-8 of the CSP (protected persons) person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure
  • Subject being excluded from another study
  • Subject who reached the ceiling of 4500 euros due to their participation in other studies involving human in the past 12 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy Volunteers

Subjects who will agree to participate to the study will be healthy subject with no particular antecedents.

Subjects will be enroled for two sessions with a 20 min monitoring phase in each session, to coect physiological data with non invasive sensors.

Synchronized signals from cardiac, respiratory and movements non invasive measurements.

One acquisition is 20 minutes long, and each subject participate to two sessions, separated by 1 to 15 days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Database of physiological signals
Time Frame: 20 minutes
Synchronized signals from embedded and non-intrusive connected devices for cardiorespiratory and motricity measurements and equivalent laboratory measurements during cycling on a cyclo-ergometer
20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the feeling of wearing equipment
Time Frame: 15 minutes
Questionnaire at the end of each session to assess the comfort / discomfort wearing the equipment used during the test
15 minutes
Criteria for the observation of a respiratory transition
Time Frame: 6 months
Feasibility of the transition detection, repeatability of the detection with the respiratory criteria
6 months
Criteria for the observation of a cardiac transition
Time Frame: 6 months
Feasibility of the transition detection, repeatability of the detection with the cardiac criteria
6 months
Criteria for the observation of a motricity transition
Time Frame: 6 months
Feasibility of the transition detection, repeatability of the detection with the motricity criteria
6 months
Multi-modal prediction of the first ventilatory threshold
Time Frame: 6 months
Correlation with the measurement of ventilatory threshold 1 (VT1)
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 5, 2023

Primary Completion (Actual)

June 11, 2024

Study Completion (Actual)

June 11, 2024

Study Registration Dates

First Submitted

November 9, 2023

First Submitted That Met QC Criteria

November 9, 2023

First Posted (Actual)

November 15, 2023

Study Record Updates

Last Update Posted (Actual)

April 1, 2025

Last Update Submitted That Met QC Criteria

March 26, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Signal acquisition

Subscribe